HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 79337Generated: October 28, 2026
m-Chloroperbenzoic acid → 4-(2-(3(3-ethyl-1-((6-methylpyridin-2-yl)methyl)-1H-indazol-4-ylcarbamoyl)imidazo[1,2-a]pyridin-7-yloxy)ethyl)-1-methylpiperazine 1-oxide
https://huagongshe.com/reaction/79337
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | m-Chloroperbenzoic acid | HCID 70297 | — |
| Reactant | N-(3-ethyl-1-((6-methylpyridin-2-yl)methyl)-1H-indazol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)imidazo[1,2-a]pyridine-3-carboxamide | HCID 53262025 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | 4-(2-(3(3-ethyl-1-((6-methylpyridin-2-yl)methyl)-1H-indazol-4-ylcarbamoyl)imidazo[1,2-a]pyridin-7-yloxy)ethyl)-1-methylpiperazine 1-oxide | HCID 86672212 | 55% |
Reaction Steps
To N-(3-ethyl-1-((6-methylpyridin-2-yl)methyl)-1H-indazol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)imidazo[1,2-a]pyridine-3-carboxamide (25 mg, 0.045 mmol; prepared according to Example 45) in DCM (3 mL) at 0° C. was added metachloroperbenzoic acid (7.8 mg, 0.032 mmol). The reaction mixture was stirred at 0° C. for one hour. The reaction mixture was concentrated under reduced pressure and silica gel chromatography (DCM/MeOH/NH4OH 10:1:0.1) provided the final product (10 mg). MS (ES+APCI) m/z=569 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08841455B2 |
|---|
| Source dataset | uspto-grants-2014_09 |
|---|
| ORD ID | ord-f445c89201564ed8a0430c5aa51c6db7 |
|---|
| Source note | uspto-grants-2014_09 |
|---|